Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.740
-0.090 (-10.84%)
At close: Apr 28, 2026, 4:00 PM EDT
0.740
-0.000 (-0.04%)
After-hours: Apr 28, 2026, 5:40 PM EDT
Werewolf Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Werewolf Therapeutics stock have an average target of 5.00, with a low estimate of 3.00 and a high estimate of 7.00. The average target predicts an increase of 575.68% from the current stock price of 0.74.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 19, 2025.
Analyst Ratings
The average analyst rating for Werewolf Therapeutics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 6 | 6 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $4 | Strong Buy | Maintains | $10 → $4 | +440.54% | Dec 19, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $8 → $7 | Strong Buy | Maintains | $8 → $7 | +845.95% | Nov 18, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | +981.08% | Aug 25, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $4 → $3 | Buy | Maintains | $4 → $3 | +305.41% | Aug 21, 2025 |
| Wedbush | Wedbush | Buy Maintains $8 → $6 | Buy | Maintains | $8 → $6 | +710.81% | May 9, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.17
from -1.33
EPS Next Year
-1.63
from -1.17
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||||
| Avg | n/a | n/a | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.77 | -1.04 | ||||||
| Avg | -1.17 | -1.63 | ||||||
| Low | -1.68 | -2.16 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.